Literature DB >> 34133926

The heme synthesis-export system regulates the tricarboxylic acid cycle flux and oxidative phosphorylation.

Veronica Fiorito1, Anna Lucia Allocco1, Sara Petrillo1, Elena Gazzano2, Simone Torretta3, Saverio Marchi4, Francesca Destefanis1, Consiglia Pacelli5, Valentina Audrito6, Paolo Provero7, Enzo Medico8, Deborah Chiabrando1, Paolo Ettore Porporato1, Carlotta Cancelliere9, Alberto Bardelli8, Livio Trusolino8, Nazzareno Capitanio5, Silvia Deaglio6, Fiorella Altruda1, Paolo Pinton10, Simone Cardaci3, Chiara Riganti2, Emanuela Tolosano11.   

Abstract

Heme is an iron-containing porphyrin of vital importance for cell energetic metabolism. High rates of heme synthesis are commonly observed in proliferating cells. Moreover, the cell-surface heme exporter feline leukemia virus subgroup C receptor 1a (FLVCR1a) is overexpressed in several tumor types. However, the reasons why heme synthesis and export are enhanced in highly proliferating cells remain unknown. Here, we illustrate a functional axis between heme synthesis and heme export: heme efflux through the plasma membrane sustains heme synthesis, and implementation of the two processes down-modulates the tricarboxylic acid (TCA) cycle flux and oxidative phosphorylation. Conversely, inhibition of heme export reduces heme synthesis and promotes the TCA cycle fueling and flux as well as oxidative phosphorylation. These data indicate that the heme synthesis-export system modulates the TCA cycle and oxidative metabolism and provide a mechanistic basis for the observation that both processes are enhanced in cells with high-energy demand.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALAS1; FLVCR; FLVCR1; FLVCR1a; cancer; heme; metabolism; oxidative phosphorylation; tricarboxylic acid cycle

Mesh:

Substances:

Year:  2021        PMID: 34133926     DOI: 10.1016/j.celrep.2021.109252

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  9 in total

1.  Complex response to physiological and drug-induced hepatic heme demand in monoallelic ALAS1 mice.

Authors:  Viktoria Vagany; Susan Robinson; Tatyana Chernova; Andrew G Smith
Journal:  Mol Genet Metab Rep       Date:  2021-11-12

Review 2.  Molecular Mechanisms of Iron and Heme Metabolism.

Authors:  Sohini Dutt; Iqbal Hamza; Thomas Benedict Bartnikas
Journal:  Annu Rev Nutr       Date:  2022-05-04       Impact factor: 9.323

3.  Targeting Mitochondrial Oxidative Phosphorylation Eradicates Acute Myeloid Leukemic Stem Cells.

Authors:  Meixi Peng; Yongxiu Huang; Ling Zhang; Xueya Zhao; Yu Hou
Journal:  Front Oncol       Date:  2022-04-29       Impact factor: 5.738

4.  The 2022 On-site Padua Days on Muscle and Mobility Medicine hosts the University of Florida Institute of Myology and the Wellstone Center, March 30 - April 3, 2022 at the University of Padua and Thermae of Euganean Hills, Padua, Italy: The collection of abstracts.

Authors:  H Lee Sweeney; Stefano Masiero; Ugo Carraro
Journal:  Eur J Transl Myol       Date:  2022-03-10

Review 5.  Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance.

Authors:  Doris Loh; Russel J Reiter
Journal:  Molecules       Date:  2022-01-21       Impact factor: 4.411

6.  Inhibition of Heme Export and/or Heme Synthesis Potentiates Metformin Anti-Proliferative Effect on Cancer Cell Lines.

Authors:  Anna Lucia Allocco; Francesca Bertino; Sara Petrillo; Deborah Chiabrando; Chiara Riganti; Alberto Bardelli; Fiorella Altruda; Veronica Fiorito; Emanuela Tolosano
Journal:  Cancers (Basel)       Date:  2022-02-27       Impact factor: 6.639

7.  Mitochondrial Respiration in Peripheral Blood Mononuclear Cells Negatively Correlates with Disease Severity in Pulmonary Arterial Hypertension.

Authors:  Natascha Sommer; Finn Fabian Theine; Oleg Pak; Khodr Tello; Manuel Richter; Henning Gall; Jochen Wilhelm; Rajkumar Savai; Norbert Weissmann; Werner Seeger; Hossein A Ghofrani; Matthias Hecker
Journal:  J Clin Med       Date:  2022-07-16       Impact factor: 4.964

8.  Epigallocatechin-3-gallate suppresses hemin-aggravated colon carcinogenesis through Nrf2-inhibited mitochondrial reactive oxygen species accumulation.

Authors:  Ju Hyung Seok; Dae Hyun Kim; Hye Jih Kim; Hang Hyo Jo; Eun Young Kim; Jae-Hwang Jeong; Young Seok Park; Sang Hun Lee; Dae Joong Kim; Sang Yoon Nam; Beom Jun Lee; Hyun Jik Lee
Journal:  J Vet Sci       Date:  2022-09       Impact factor: 1.603

9.  Hemopexin and Cancer.

Authors:  Veronica Fiorito; Emanuela Tolosano
Journal:  Int J Mol Sci       Date:  2022-01-17       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.